TAILORING CONSENT FOR INNOVATIVE THERAPIES

被引:1
|
作者
CACCIATORE, GG
机构
[1] Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, 77030, TX
关键词
D O I
10.1093/ajhp/52.6.600
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:600 / 601
页数:2
相关论文
共 50 条
  • [41] (R)Evolution with innovative Combination Therapies
    Junker, Annette
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 708 - 708
  • [42] Innovative therapies for malignant pleural mesothelioma
    Roberts, JR
    CHEST, 1997, 112 (04) : S269 - S271
  • [43] GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    COHEN, IL
    CRITICAL CARE MEDICINE, 1993, 21 (03) : 476 - 477
  • [44] Immune Checkpoints and Innovative Therapies in Glioblastoma
    Romani, Massimo
    Pistillo, Maria Pia
    Carosio, Roberta
    Morabito, Anna
    Banelli, Barbara
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [45] European regulatory perspectives for innovative therapies
    Ormarsdottir, S.
    Reginster, J. -Y.
    Abadie, E.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (06) : 725 - 731
  • [46] Developing innovative targeted therapies for China
    Bahija Jallal
    Journal of Translational Medicine, 10 (Suppl 2)
  • [47] Innovative therapies for advanced ovarian cancer
    Trimble, EL
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 24 - 30
  • [48] European regulatory perspectives for innovative therapies
    S. Ormarsdottir
    J.-Y. Reginster
    E. Abadie
    Osteoporosis International, 2008, 19 : 725 - 731
  • [49] Skin aging: Pathophysiology and innovative therapies
    Boismal, Francoise
    Serror, Kevin
    Dobos, Gabor
    Zuelgaray, Elina
    Bensussan, Armand
    Michel, Laurence
    M S-MEDECINE SCIENCES, 2020, 36 (12): : 1163 - 1172
  • [50] Relapsed and Refractory HL: Innovative Therapies
    von Tresckow, Bastian
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 : 24 - 24